Department of Palliative Care and Oncology, University Children's Hospital Zurich, Steinwiesstrasse 75, CH-8032, Zurich, Switzerland.
BMC Palliat Care. 2013 May 8;12(1):20. doi: 10.1186/1472-684X-12-20.
The introduction of paediatric palliative care and referral to specialised teams still occurs late in the illness trajectory of children with life-limiting diseases. The aim of this ongoing multipart study was to develop a screening instrument for paediatricians that would improve the timely identification of children who could benefit from a palliative care approach.
We used a qualitative study approach with semi-structured interviews (Part 1) and a focus group discussion (Part 2) to define the domains and items of the screening instrument. Seven international paediatric palliative care experts from the UK, France, USA, and Canada took part in face-to-face interviews, and eleven paediatric health professionals from the University Children's Hospital, Zurich, participated in a subsequent focus group discussion.
This preliminary phase of development and validation of the instrument revealed five domains relevant to identifying children with life-limiting diseases, who could benefit from palliative care: 1) trajectory of disease and impact on daily activities of the child; 2) expected outcome of disease-directed treatment and burden of treatment; 3) symptom and problem burden; 4) preferences of patient, parents or healthcare professional; and 5) estimated life expectancy. Where palliative care seems to be necessary, it would be introduced in a stepwise or graduated manner.
This study is a preliminary report of the development of an instrument to facilitate timely introduction of palliative care in the illness trajectory of a severely ill child. The instrument demonstrated early validity and was evaluated as being a valuable approach towards effective paediatric palliative care.
儿科姑息治疗的引入和向专业团队的转介仍然发生在患有危及生命疾病的儿童的疾病进程后期。本正在进行的多部分研究的目的是为儿科医生开发一种筛选工具,以提高及时识别可能受益于姑息治疗方法的儿童的能力。
我们使用定性研究方法,包括半结构化访谈(第 1 部分)和焦点小组讨论(第 2 部分),以确定筛选工具的领域和项目。来自英国、法国、美国和加拿大的 7 位国际儿科姑息治疗专家参加了面对面访谈,来自苏黎世大学儿童医院的 11 位儿科保健专业人员参加了随后的焦点小组讨论。
该工具的初步开发和验证阶段揭示了五个与识别患有危及生命疾病、可能受益于姑息治疗的儿童相关的领域:1)疾病轨迹和对儿童日常活动的影响;2)疾病导向治疗的预期结果和治疗负担;3)症状和问题负担;4)患者、家长或医疗保健专业人员的偏好;和 5)预期寿命。如果姑息治疗似乎是必要的,将以逐步或分级的方式引入。
本研究初步报告了一种工具的开发,以促进在重病儿童的疾病进程中及时引入姑息治疗。该工具表现出早期有效性,并被评估为一种有效的儿科姑息治疗方法。